These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
424 related articles for article (PubMed ID: 24291067)
1. Are macrophages, myeloid derived suppressor cells and neutrophils mediators of local suppression in healthy and cancerous tissues in aging hosts? Jackaman C; Nelson DJ Exp Gerontol; 2014 Jun; 54():53-7. PubMed ID: 24291067 [TBL] [Abstract][Full Text] [Related]
3. Aging and cancer: The role of macrophages and neutrophils. Jackaman C; Tomay F; Duong L; Abdol Razak NB; Pixley FJ; Metharom P; Nelson DJ Ageing Res Rev; 2017 Jul; 36():105-116. PubMed ID: 28390891 [TBL] [Abstract][Full Text] [Related]
4. Tumor-host immune interactions and dendritic cell dysfunction. Yang L; Carbone DP Adv Cancer Res; 2004; 92():13-27. PubMed ID: 15530555 [TBL] [Abstract][Full Text] [Related]
5. Immune response regulation in the tumor microenvironment by hypoxia. Labiano S; Palazon A; Melero I Semin Oncol; 2015 Jun; 42(3):378-86. PubMed ID: 25965356 [TBL] [Abstract][Full Text] [Related]
6. Myeloid cells as effector cells for monoclonal antibody therapy of cancer. Braster R; O'Toole T; van Egmond M Methods; 2014 Jan; 65(1):28-37. PubMed ID: 23811299 [TBL] [Abstract][Full Text] [Related]
10. Inflammatory cell infiltration of tumors: Jekyll or Hyde. Talmadge JE; Donkor M; Scholar E Cancer Metastasis Rev; 2007 Dec; 26(3-4):373-400. PubMed ID: 17717638 [TBL] [Abstract][Full Text] [Related]
11. Regulatory T cells, dendritic cells and neutrophils in patients with renal cell carcinoma. Minárik I; Lašťovička J; Budinský V; Kayserová J; Spíšek R; Jarolím L; Fialová A; Babjuk M; Bartůňková J Immunol Lett; 2013 May; 152(2):144-50. PubMed ID: 23721909 [TBL] [Abstract][Full Text] [Related]
12. Innate Immune Defense Mechanisms by Myeloid Cells That Hamper Cancer Immunotherapy. Lebegge E; Arnouk SM; Bardet PMR; Kiss M; Raes G; Van Ginderachter JA Front Immunol; 2020; 11():1395. PubMed ID: 32733461 [TBL] [Abstract][Full Text] [Related]
13. Myeloid cells as orchestrators of the tumor microenvironment: novel targets for nanoparticular cancer therapy. Tuettenberg A; Steinbrink K; Schuppan D Nanomedicine (Lond); 2016 Oct; 11(20):2735-2751. PubMed ID: 27658725 [TBL] [Abstract][Full Text] [Related]
14. [Suppressor cells - the basis of the immunopathogenesis of cancer]. Kozlov VA Vopr Onkol; 2016; 62(3):390-6. PubMed ID: 30462899 [TBL] [Abstract][Full Text] [Related]
15. Antigen specificity of immune suppression by myeloid-derived suppressor cells. Solito S; Bronte V; Mandruzzato S J Leukoc Biol; 2011 Jul; 90(1):31-6. PubMed ID: 21486906 [TBL] [Abstract][Full Text] [Related]
16. Tumour-induced immune suppression: role of inflammatory mediators released by myelomonocytic cells. Mao Y; Poschke I; Kiessling R J Intern Med; 2014 Aug; 276(2):154-70. PubMed ID: 24597954 [TBL] [Abstract][Full Text] [Related]
18. IL-2/CD40-activated macrophages rescue age and tumor-induced T cell dysfunction in elderly mice. Jackaman C; Dye DE; Nelson DJ Age (Dordr); 2014 Jun; 36(3):9655. PubMed ID: 24744051 [TBL] [Abstract][Full Text] [Related]
19. Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses. Hossain F; Majumder S; Ucar DA; Rodriguez PC; Golde TE; Minter LM; Osborne BA; Miele L Front Immunol; 2018; 9():1288. PubMed ID: 29915603 [TBL] [Abstract][Full Text] [Related]
20. Aging, immunity and cancer. Hakim FT; Flomerfelt FA; Boyiadzis M; Gress RE Curr Opin Immunol; 2004 Apr; 16(2):151-6. PubMed ID: 15023406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]